Stages in the development of Parkinson’s disease-related pathology
|
journal
|
August 2004 |
In vivo imaging of the vesicular acetylcholine transporter and the vesicular monoamine transporter
|
journal
|
December 2000 |
Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles.
|
journal
|
April 1996 |
PET imaging of cholinergic deficits in rats using [18F]fluoroethoxybenzovesamicol ([18F]FEOBV)
|
journal
|
August 2012 |
Synthesis and in Vitro and in Vivo Evaluation of 18 F-Labeled Positron Emission Tomography (PET) Ligands for Imaging the Vesicular Acetylcholine Transporter
|
journal
|
March 2009 |
Behavioural state differentially engages septohippocampal cholinergic and GABAergic neurons in R6/1 Huntington’s disease mice
|
journal
|
February 2012 |
Development of novel PET probe [ 11 C]( R , R )HAPT and its stereoisomer [ 11 C]( S , S )HAPT for vesicular acetylcholine transporter imaging: A PET study in conscious monkey: Vacht Imaging With [ 11 c]( R , R )Hapt
|
journal
|
April 2014 |
Measuring the rate of progression of Parkinson's disease over a 5-year period with β-CIT SPECT: Progression of Parkinson's Disease
|
journal
|
July 2003 |
Comparison of Methods for Analysis of Clinical [ 11 C]Raclopride Studies
|
journal
|
January 1996 |
Kinetics modeling and occupancy studies of a novel C-11 PET tracer for VAChT in nonhuman primates
|
journal
|
February 2016 |
Simplified Reference Tissue Model for PET Receptor Studies
|
journal
|
December 1996 |
Positron emission tomography imaging of (2R,3R)-5-[18F]fluoroethoxybenzovesamicol in rat and monkey brain: a radioligand for the vesicular acetylcholine transporter
|
journal
|
July 2009 |
Heteroaromatic and Aniline Derivatives of Piperidines As Potent Ligands for Vesicular Acetylcholine Transporter
|
journal
|
July 2013 |
Synthesis and binding affinities of methylvesamicol analogs for the acetylcholine transporter and sigma receptor
|
journal
|
April 2006 |
Selective coexpression of synaptic proteins, α-synuclein, cysteine string protein-α, synaptophysin, synaptotagmin-1, and synaptobrevin-2 in vesicular acetylcholine transporter-immunoreactive axons in the guinea pig ileum: Selective Expression of Synaptic Proteins in Cholinergic Neurons in the Gut
|
journal
|
June 2013 |
Cortical Cholinergic Function Is More Severely Affected in Parkinsonian Dementia Than in Alzheimer Disease: An In Vivo Positron Emission Tomographic Study
|
journal
|
December 2003 |
Regulation of cholinergic activity by the vesicular acetylcholine transporter
|
journal
|
February 2013 |
Synthesis and evaluation of vesamicol analog (-)-o-[11C]methylvesamicol as a PET ligand for vesicular acetylcholine transporter
|
journal
|
July 2006 |
Comparison of Noninvasive Quantification Methods of in Vivo Vesicular Acetylcholine Transporter Using [ 123 I]-IBVM SPECT Imaging
|
journal
|
May 2008 |
Stoichiometries of Acetylcholine Uptake, Release, and Drug Inhibition in Torpedo Synaptic Vesicles: Heterogeneity in Acetylcholine Transport and Storage
|
journal
|
April 1986 |
Radiation dosimetry of [18F]VAT in nonhuman primates
|
journal
|
December 2015 |
Synthesis and in Vitro Biological Evaluation of Carbonyl Group-Containing Analogues for σ 1 Receptors
|
journal
|
August 2011 |
In Vivo Imaging of Human Cholinergic Nerve Terminals with (-)-5-18F-Fluoroethoxybenzovesamicol: Biodistribution, Dosimetry, and Tracer Kinetic Analyses
|
journal
|
January 2014 |
Quantification of brain cholinergic denervation in Alzheimer’s disease using PET imaging with [18F]-FEOBV
|
journal
|
September 2017 |
Automated production of [ 18 F]VAT suitable for clinical PET study of vesicular acetylcholine transporter
|
journal
|
January 2016 |
[123I]-IBVM SPECT imaging of cholinergic systems in multiple system atrophy: A specific alteration of the ponto-thalamic cholinergic pathways (Ch5–Ch6)
|
journal
|
January 2013 |
Effects of Blood Flow on [ 11 C]Raclopride Binding in the Brain: Model Simulations and Kinetic Analysis of PET Data
|
journal
|
November 1994 |
Kinetic and equilibrium analyses of [123I]epidepride binding to striatal and extrastriatal dopamine D2 receptors
|
journal
|
December 1999 |
PET imaging with [18F]fluoroethoxybenzovesamicol ([18F]FEOBV) following selective lesion of cholinergic pedunculopontine tegmental neurons in rat
|
journal
|
January 2014 |
Concordance between in vivo and postmortem measurements of cholinergic denervation in rats using PET with [18F]FEOBV and choline acetyltransferase immunochemistry
|
journal
|
January 2013 |
Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [ N - 11 C-Methyl]-(−)-Cocaine PET Studies in Human Subjects
|
journal
|
September 1990 |
Synthesis and evaluation of in vitro bioactivity for vesicular acetylcholine transporter inhibitors containing two carbonyl groups
|
journal
|
July 2012 |
MRI-PET Registration with Automated Algorithm
|
journal
|
January 1993 |
Interactive reconstruction in single-photon tomography
|
journal
|
April 1989 |
A new look at the statistical model identification
|
journal
|
December 1974 |
In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease
|
journal
|
September 1996 |
Measuring Drug Occupancy in the Absence of a Reference Region: The Lassen Plot Re-Visited
|
journal
|
September 2009 |
The cholinergic system and Parkinson disease
|
journal
|
August 2011 |
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced acute transient dystonia in monkeys associated with low striatal dopamine
|
journal
|
January 2006 |
Synthesis and in Vitro Biological Evaluation of Carbonyl Group-Containing Inhibitors of Vesicular Acetylcholine Transporter
|
journal
|
April 2010 |
From Graphical Analysis to Multilinear Regression Analysis of Reversible Radioligand Binding
|
journal
|
July 1996 |
Selective expression of α-synuclein-immunoreactivity in vesicular acetylcholine transporter-immunoreactive axons in the guinea pig rectum and human colon
|
journal
|
December 2012 |
Deficit in sustained attention following selective cholinergic lesion of the pedunculopontine tegmental nucleus in rat, as measured with both post-mortem immunocytochemistry and in vivo PET imaging with [18F]fluoroethoxybenzovesamicol
|
journal
|
February 2015 |
Synthesis and biological characterization of stable and radioiodinated (±)-trans-2-hydroxy-3-P{4-(3-iodophenyl)piperidyl}-1,2,3,4-tetrahydronaphthalene (3′-IBVM)
|
journal
|
November 2000 |
Ex vivo and in vivo evaluation of (2R,3R)-5-[18F]-fluoroethoxy- and fluoropropoxy-benzovesamicol, as PET radioligands for the vesicular acetylcholine transporter
|
journal
|
January 2007 |
Cholinergic system function and cognition in mild cognitive impairment
|
journal
|
May 2012 |
Age-associated leukoaraiosis and cortical cholinergic deafferentation
|
journal
|
April 2009 |
Effects of Temporal Sampling, Glucose Metabolic Rates, and Disruptions of the Blood—Brain Barrier on the FDG Model with and without a Vascular Compartment: Studies in Human Brain Tumors with PET
|
journal
|
April 1986 |
Synthesis and biological characterization of a promising F-18 PET tracer for vesicular acetylcholine transporter
|
journal
|
August 2015 |